History of pharmacy in the United States of its discoverer, which became the first effective treatment for malaria. The active ingredient of this cinchona bark, quinine, was the primary treatment for malaria well into the 1940s. "About 170 drugs used by the Indians of British North America, and perhaps 50 used by the indigenous people of the Caribbean, Mexico, Central and South America" became important enough in the U.S. (as the practitioners of chemistry and pharmacy eventually catalogued, analyzed and understood them) to merit listing in the United States Pharmacopoeia (est. 1820) or the National Formulary. In the early 1700s, James Oglethorpe, founder of the Georgia colony,
Cinchona South America, the species had geographically distinct distributions. The introduction of several species into cultivation in the same areas in India and Java, respectively, by the English and Dutch East India Companies led to the formation of hybrids. Linnaeus described the genus based on the species "Cinchona officinalis." Nearly 300 species have been described and named in the genus but a revision of the genus in 1998 identified 23 distinct species. The febrifugal properties of bark from trees now known to be in the genus "Cinchona" were used by many South American cultures but malaria was an Old World disease